Primo partners with SHINE to bring Ilumira (Lu-177) to Asia-Pacific, advancing radioligand therapy and precision cancer care with exclusive rights in key markets.
Primo partners with SHINE to bring Ilumira (Lu-177) to Asia-Pacific, advancing radioligand therapy and precision cancer care with exclusive rights in key markets.